| Name | Title | Contact Details |
|---|---|---|
Mark Lenkiewicz |
Sr. Associate Director, Human Resources | Profile |
Corrie Falciano |
Senior Associate Director, Financial | Profile |
Jared Kurtz |
Vice President, ILD and Respiratory Sales | Profile |
Dominik Zimmerli |
Vice President, Human Resources | Profile |
Lauren Mascolo |
Executive Director, Human Resources | Profile |
Aria Care Partners is the leading provider of onsite ancillary medical services for skilled nursing facilities. With more than 20 years of partnership with 2500+ skilled nursing facilities, Aria Care Partners remains on the leading edge of innovative care delivery, understanding the connection between dental, vision, and hearing services to resident health and well-being. With a unique combination of turnkey insurance solutions and innovative service delivery, Aria Care Partners is passionate about enriching every resident`s quality of life and ensuring that every family knows their loved ones are well cared for and safe.
Ryan Brothers Ambulance is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our foundation supports many programs throughout the Brooks System of Care, including clinical research, adaptive sports and wellness, school re-entry, and free care for those who need it most. Our Volunteer Services department provides an opportunity for personal growth, education, and service to others. Our goal is to meet the needs of our volunteers while carrying out our vision of providing world-class service to our patients. Volunteer assignments are made according to interest, availability, and the skills needed to fulfill task requirements.
Regional Nursing Services is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.